Research projects focus on the diagnosis and treatment of childhood tuberculosis in the international setting, the elimination of HIV transmission to at-risk youth, best practices of HIV mother-to-child transmission prevention, treatment of HIV infection in infants, children, adolescents, and young adults, and outcomes in perinatally HIV-infected youth. See information about our international research conducted by BIPAI.
Pediatric Retrovirology operates within the Section of Immunology, Allergy and Retrovirology and conducts clinical studies sponsored by the NIH through three Networks. The Adolescent Trials Network’s primary mission is to conduct both independent and collaborative research that explores promising behavioral, microbicidal, prophylactic, therapeutic, and vaccine modalities in HIV-infected and at-risk adolescents, ages 12 years through 24 years. The International Maternal Pediatric Adolescent AIDS Clinical Trials Group’s goals are to improve health outcomes for infants, children and adolescents, and pregnant/postpartum women who are impacted by or living with HIV by evaluating novel treatments and interventions for HIV and it’s complications and for tuberculosis and other HIV-related conditions. Lastly, the Pediatric HIV/ AIDS Cohort is a longitudinal cohort study investigating the long-term effects of HIV and antiretroviral medications in children and young adults who were born with HIV or born exposed to HIV. The study follows newborns, young children, adolescents, and young adults.